Friday 6 November 2026 Export COO’s income statement to Excel — free account

The Cooper Companies, Inc.

COO Healthcare Medical Instruments & Supplies

The Cooper Companies, Inc.’s revenue for fiscal 2025 (year ended October 2025) was $4.1 billion, up 5.06% from fiscal 2024.

Revenue: +0.56%
EPS: +357.1%
Free cash flow: +66.0%
Total debt: +2.66%

Quarter to July 2026, against a year earlier

63.44 0.98 −1.52%

Follow COO

Alert me

Market cap: $12.1B
P/E: 21.7×
Fwd P/E: 17.5×
Dividend yield: —
F-score: 5/9
Altman Z: 3.48
Beneish M: −2.50
Dividend safety: n/a

Overview Business Profile Earnings & Analysis Segments Valuation Filings

The Cooper Companies, Inc. 10-Q filed May 30, 2025

Fiscal Q2 2025 · Period ended Apr 30, 2025 · Filed May 30, 2025 · accepted 4:19 PM ET · Document on sec.gov · Filing index

Red flags

Material weakness May 30, 2025
The Cooper Companies, Inc.’s 10-Q reports a material weakness in internal control over financial reporting

Based on management’s evaluation (with the participation of our Chief Executive Officer (our Principal Executive Officer) and Chief Financial Officer (our Principal Financial Officer)), as of the end of the period covered by this report, due to the material weakness described below, our Chief Executive Officer and Chief Financial Officer have concluded that our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended, (the Exchange Act)) are not effective as of April 30, 2025 to provide reasonable assurance that information required to be disclosed by us in reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in Securities and Exchange Commission rules and forms and is accumulated and communicated to management, including our Chief Executive Officer and Chief Financial Officer, as appropriate to allow timely decisions regarding required disclosure.

10-Q filed May 30, 2025 · The filing · sec.gov